ArticleBMC pulmonary medicine2024

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.

Tejaswini Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.